Skip to main content
. 2019;20(10):3077–3084. doi: 10.31557/APJCP.2019.20.10.3077

Table 2.

Distribution of Clinical Variables among Study and Comparison Group in Pretest (N = 120)

S.
No.
Clinical variables Study group
n=60
Comparison group
n=60
Univariate analysis&‘p’ value
No. % No. %
1 Diagnosis
a.Ca. breast (Right) 36 60.0 36 60.0 p =0.162
NS
b. Ca. breast (Left) 24 40.0 24 40.0
2 Stage of cancer breast
a. Stage IIA 8 13.3 13 21.7 p =0.437
NS
b. Stage IIB 37 61.7 32 53.3
c. Stage IIIA 14 23.3 13 21.7
d. Stage IIIB 1 1.7 2 3.3
3 Type of surgery
a. Modified radical mastectomy 59 98.3 57 95.0 p =0.817
NS
b. Radical mastectomy (Total) 1 1.7 3 5.0
4 Axillary node dissection status
a. Level I – III 60 100 56 93.3 p =0.701
NS
b. Level I – II - - 4 6.7
5 Side of surgery
a. Dominant 36 60.0 36 60.0 p =0.162
NS
b. Non Dominant 24 40.0 24 40.0
6 Co-morbid illness
a. Diabetes mellitus 10 16.7 16 26.7 p =0.833
NS
b. Hypertension 4 6.7 11 18.3
c. Hypertension and Diabetes 10 16.7 11 18.3
d. None 36 60.0 22 36.7

NS-Not significant; *p<0.05